InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,615.28
(
-0.34%
)
US TECH 100
19,033.00
(
-0.87%
)
Dow Jones
41,221.45
(
0.11%
)
Brent Oil
80.32
(
2.48%
)
Bitcoin
63,515.89
(
-1.31%
)
Post# of 252975
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 837
Posts 120334
Boards Moderated 18
Alias Born 09/05/2002

DewDiligence

Member Level

Re: wallstarb post# 82392

Friday, 08/14/2009 6:36:49 PM

Friday, August 14, 2009 6:36:49 PM

Post# of 252975

BPAX yet another biotech scam

I don’t agree. To the contrary, I think LibiGel has a good chance to be a big-selling drug.

The addressable market—women who want better sex—is obviously a large one, and low-dose testosterone has proven efficacy in raising female libido. If not for the FDA’s near-maniacal obsession with the safety of “lifestyle” drugs, LibiGel and Intrinsa, a similar drug from PG, would already be on the market.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up